These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29726940)

  • 1. Statistical primer: a cost-effectiveness analysis.
    Antonides CFJ; Cohen DJ; Osnabrugge RLJ
    Eur J Cardiothorac Surg; 2018 Aug; 54(2):209-213. PubMed ID: 29726940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B).
    Reynolds MR; Magnuson EA; Wang K; Lei Y; Vilain K; Walczak J; Kodali SK; Lasala JM; O'Neill WW; Davidson CJ; Smith CR; Leon MB; Cohen DJ;
    Circulation; 2012 Mar; 125(9):1102-9. PubMed ID: 22308299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
    Doble B; Blackhouse G; Goeree R; Xie F
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).
    Reynolds MR; Magnuson EA; Lei Y; Wang K; Vilain K; Li H; Walczak J; Pinto DS; Thourani VH; Svensson LG; Mack MJ; Miller DC; Satler LE; Bavaria J; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2012 Dec; 60(25):2683-92. PubMed ID: 23122802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
    Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
    Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
    Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of the cost-effectiveness of transcatheter aortic valve implantation.
    Indraratna P; Ang SC; Gada H; Yan TD; Manganas C; Bannon P; Cao C
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):509-14. PubMed ID: 24280719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.
    Reynolds MR; Lei Y; Wang K; Chinnakondepalli K; Vilain KA; Magnuson EA; Galper BZ; Meduri CU; Arnold SV; Baron SJ; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    J Am Coll Cardiol; 2016 Jan; 67(1):29-38. PubMed ID: 26764063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings.
    Hancock-Howard RL; Feindel CM; Rodes-Cabau J; Webb JG; Thompson AK; Banz K
    J Med Econ; 2013; 16(4):566-74. PubMed ID: 23356420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of transcatheter valvular interventions: economic challenges.
    Osnabrugge RL; Kappetein AP; Reynolds MR; Cohen DJ
    EuroIntervention; 2013 Sep; 9 Suppl():S48-54. PubMed ID: 24025958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants.
    Ribera A; Slof J; Andrea R; Falces C; Gutiérrez E; Del Valle-Fernández R; Morís-de la Tassa C; Mota P; Oteo JF; Cascant P; Altisent OA; Sureda C; Serra V; García-Del Blanco B; Tornos P; Garcia-Dorado D; Ferreira-González I
    Int J Cardiol; 2015 Mar; 182():321-8. PubMed ID: 25585368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement.
    Watt M; Mealing S; Eaton J; Piazza N; Moat N; Brasseur P; Palmer S; Busca R; Sculpher M
    Heart; 2012 Mar; 98(5):370-6. PubMed ID: 22076021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of aortic valve replacement in the elderly: an introductory study.
    Wu Y; Jin R; Gao G; Grunkemeier GL; Starr A
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):608-13. PubMed ID: 17320552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of illness in cost-effectiveness analysis. A review of the methodology.
    Hodgson TA
    Pharmacoeconomics; 1994 Dec; 6(6):536-52. PubMed ID: 10155283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients.
    Osnabrugge RL; Head SJ; Genders TS; Van Mieghem NM; De Jaegere PP; van der Boon RM; Kerkvliet JM; Kalesan B; Bogers AJ; Kappetein AP; Hunink MG
    Ann Thorac Surg; 2012 Dec; 94(6):1954-60. PubMed ID: 22959568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of transcatheter aortic valve replacement compared with medical management or surgery for patients with aortic stenosis.
    Iannaccone A; Marwick TH
    Appl Health Econ Health Policy; 2015 Feb; 13(1):29-45. PubMed ID: 25488391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature.
    Talmor D; Shapiro N; Greenberg D; Stone PW; Neumann PJ
    Crit Care Med; 2006 Nov; 34(11):2738-47. PubMed ID: 16957636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is transcatheter aortic valve implantation (TAVI) a cost-effective treatment in patients who are ineligible for surgical aortic valve replacement? A systematic review of economic evaluations.
    Eaton J; Mealing S; Thompson J; Moat N; Kappetein P; Piazza N; Busca R; Osnabrugge R
    J Med Econ; 2014 May; 17(5):365-75. PubMed ID: 24611813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research.
    Am J Respir Crit Care Med; 2002 Feb; 165(4):540-50. PubMed ID: 11850349
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.